Close Menu
Business News MEA
    Facebook X (Twitter) Instagram
    Wednesday, October 21
    Facebook X (Twitter) Instagram LinkedIn VKontakte
    Business News MEABusiness News MEA
    • Home
    • UAE
    • Business
    • Technology
    • Lifestyle
    • Sports
    Business News MEA
    You are at:Home»UAE»Mubadala Bio, Marcyrl Group sign strategic partnership to localize women’s health, fertility and respiratory therapies in UAE
    UAE

    Mubadala Bio, Marcyrl Group sign strategic partnership to localize women’s health, fertility and respiratory therapies in UAE

    Editorial TeamBy Editorial TeamOctober 21, 2026
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    ABU DHABI, 21st October, 2026 (WAM) — Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localize a broad portfolio of women’s health, fertility and respiratory products in the UAE. Dr. Essam Mohamed, Group Chief Executive Officer of Mubadala Bio, and Dr. George Saad, Chief Executive Officer of Marcyrl Group, signed the agreement at the Future Health Summit in Abu Dhabi.

    The partnership will bring a portfolio of women’s health and fertility medicines to the UAE, supporting women across key stages of reproductive health, from fertility and pregnancy through to childbirth, alongside treatments for common gynecological and hormonal conditions. The respiratory portfolio will address a range of acute and chronic respiratory conditions and includes metered dose inhalers, dry powder inhalers, nebulization solutions and nasal sprays. Together, the two portfolios will be localized and distributed in the UAE, with further products expected to be added over time.

    Dr. Essam Mohamed, Group Chief Executive Officer of Mubadala Bio, said: ” Localizing pharmaceutical products is central to building a resilient life sciences ecosystem in the UAE. Women’s health is a priority therapy area for Mubadala Bio and our partnership with Marcyrl, which also includes respiratory medicines, allows us to localize a comprehensive portfolio of products and expand access to important treatments across the UAE.”

    Dr. George Saad, Chief Executive Officer of Marcyrl Group said: “This partnership marks an important step in expanding access to essential medicines in the UAE and across the GCC. By combining Marcyrl Group’s manufacturing expertise in women’s health, fertility and respiratory care with Mubadala Bio’s regional platform, we will advance localization, strengthen healthcare resilience and improve patient access to quality treatments.”

    The agreement supports Mubadala Bio’s broader efforts to strengthen local pharmaceutical capabilities, expand access to priority therapies, and contribute to an integrated life sciences ecosystem in the UAE.

    Source: Emirates News Agency

    Previous ArticleTDRA, ITU organise UAE Capacity Building Week
    Next Article Future Health, Bridge for Billions to launch programme strengthening health entrepreneurship in emerging markets

    Related Posts

    Future Health, Bridge for Billions to launch programme strengthening health entrepreneurship in emerging markets

    October 21, 2026

    Sharjah CP visits Little Police Officer Early Childhood Centre

    October 21, 2026

    DoH leads strategic partnership with MSD, DSV and RAFED to establish regional logistics hub for medicines and vaccines in Abu Dhabi

    October 21, 2026
    Don't Miss

    Future Health, Bridge for Billions to launch programme strengthening health entrepreneurship in emerging markets

    Mubadala Bio, Marcyrl Group sign strategic partnership to localize women’s health, fertility and respiratory therapies in UAE

    TDRA, ITU organise UAE Capacity Building Week

    Fifth Mubadala Abu Dhabi Open to feature 28 singles players and 16 doubles teams

    2026. All rights reserved.
    • Home
    • UAE
    • Business
    • Technology
    • Lifestyle
    • Sports
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.